The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Home | ERA Neph-Manual

ERA Neph-Manual


5 / 5 results found

{%SMALL_TITLE%}
{%SUMMARY_INFO%}

{%BOTTOM_TEXT%}

{%SMALL_TITLE%}

{%EXCERPT%}

{%BOTTOM_TEXT%}

Speaker
Ewout Hoorn, The Netherlands

Panellists
Turgay Saritas, Germany
Giovambattista Capasso, Italy

Moderator
Jeroen Kooman, The Netherlands

Wednesday, December 4, 2024, 5:00 PM (CET)

ERA Neph-Manual